ARCHIVES

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Patients “Raise A Voice” For Provenge Approval.

April 27, 2007

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

AACI Told Medicare “Probably” Has Paid For Extra Patient Care Costs Of Research; Members Object To “Two Level System”

July 27, 1984

Clearinghouse Group Selects 10 More Compounds To Test

January 13, 1978

In Brief: NCAB Appointments: Boutwell Stay On; Brown, Elion, Strong, Korn Named; One Vacancy Remains

May 18, 1984

Funding Opportunities: ACS Calif. Division Calls for Applications

August 1, 1997